11 Aug View of Commercial League National Pharma Center on the Recent Cost-Cutting Effort
The new approach of pressuring pharmaceutical manufacturers and distributors into cutting costs and deferring debts payable by the NHIF is disgraceful and will hardly have the desired effect. It cuts off paths to improvement in patient accessibility to reimbursed medicines, to achieving stability in the drug-supply market and restricted budget implementation....